Maitreya Medicare Limited

Maitreya Medicare Limited (MAITREYA) is a micro-cap Healthcare company valued at ₹86 crore operating in Hospital on the NSE and BSE.

Recent price move

Maitreya Medicare Limited last traded at ₹126.5, modestly up 0.60% on the day.

Recent developments

On 2026-03-31, the company reported a net loss of ₹2 crore for the latest financial year, marking a swing from a profit of ₹2 crore the previous year. In the latest quarter, the company recorded a loss of ₹2 crore, down from a net profit of ₹0 crore in the same quarter a year earlier.

Financial performance

The company's business has deteriorated, with annual net profit swinging from a profit of ₹2 crore to a loss of ₹2 crore. The latest quarter showed a loss of ₹2 crore, down from a net profit of ₹0 crore in the same quarter a year earlier. Margins have collapsed, with the net profit margin falling to -5.5% from 4.2% the prior year, and returns remain negative.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 3.38 times book value.

Things to watch

The company is currently in a net loss, with a net profit margin of -5.5%. Returns on equity and capital employed are both negative, indicating poor profitability. The stock is 59.9% below its 52-week high, and the company has reported a loss in its latest financial year.

Where it stands

Maitreya Medicare Limited ended its latest financial year with a net loss of ₹2 crore, down from a profit of ₹2 crore the previous year. The latest quarter also showed a loss of ₹2 crore, compared to a net profit of ₹0 crore in the same quarter a year earlier. The most significant movement was the collapse in net profit margin to -5.5%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.